tazobactam has been researched along with Acute Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Li, Z; Sun, F; Wang, D; Xu, R | 1 |
| Cies, JJ; Kuti, JL; Monogue, ML; Muhlebach, M; Nicolau, DP; Pettit, RS | 1 |
| Kılıç, SC; Sarper, N; Zengin, E | 1 |
| Hansson, J; Johnsson, E; Jönsson, C; Körner, U; Ludwigs, K; Lundholm, K | 1 |
| Adeyi, B; Angel-Muller, E; Hague, C; Higareda, I; Ismail, M; Roy, S; Teppler, H; Woods, GL | 1 |
| Benner, A; Egerer, G; Geiss, HK; Goldschmidt, H; Harter, C; Ho, AD; Hoppe-Tichy, T; Schulze, B | 1 |
| Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
5 trial(s) available for tazobactam and Acute Disease
| Article | Year |
|---|---|
Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Patient Safety; Penicillanic Acid; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Tazobactam | 2016 |
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult | 2011 |
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lactams; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome | 2003 |
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Predictive Value of Tests; Prospective Studies; Survival Rate; Tazobactam; Transplantation, Autologous; Treatment Outcome | 2006 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
2 other study(ies) available for tazobactam and Acute Disease
| Article | Year |
|---|---|
Acute septic arthritis of shoulder joint caused by Aeromonas veronii biotype sobria.
Topics: Acute Disease; Aeromonas veronii; Aged, 80 and over; Arthritis, Infectious; Arthrocentesis; Cefoperazone; Female; Fever; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Levofloxacin; Shoulder Joint; Tazobactam; Treatment Outcome | 2018 |
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam | 2012 |